J&J seeks drug regulator s nod to study its Covid-19 jab on adolescents uniindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uniindia.com Daily Mail and Mail on Sunday newspapers.
Senhwa concludes enrolment in Phase II oral Covid-19 drug trial clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.
Currently, those that have received a single jab or have been completely vaccinated abroad cannot receive such a certificate. However, off late, since international travel has been opening up, a certificate becomes necessary in order to facilitate the same.
Synopsis
In May, Bharat Biotech said an EUL application had been submitted to the WHO. The world health body had held a “pre-submission” meeting with Bharat Biotech on June 23.
AFP
The World Health Organization is likely to decide on emergency use listing (EUL) of Bharat Biotech s Covaxin by the end of August, WHO chief Scientist Soumya Swaminathan told ET. So far, the world body has approved Covid-19 vaccines developed by Pfizer-BioNTech, Oxford-AstraZeneca (Covishield in India), Johnson & Johnson, Moderna and Sinopharm for emergency use.
In May, Bharat Biotech said an EUL application had been submitted to the WHO. The world health body had held a “pre-submission” meeting with Bharat Biotech on June 23.